Ceftaroline China Pharmacokinetics Study

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Healthy
Interventions
DRUG

Ceftaroline

60-minute single intravenous dose of 600 mg of Ceftaroline on Days 1 and 8; 60-minute intravenous dose of 600 mg of Ceftaroline twice per day on Days 3-7.

DRUG

Ceftaroline

Single intravenous dose on Days 1 and 9. Intravenous three times per day on Days 2-8.

Trial Locations (1)

Unknown

Beijing

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Pfizer

INDUSTRY

NCT01458743 - Ceftaroline China Pharmacokinetics Study | Biotech Hunter | Biotech Hunter